Proteomics International is proud to announce it has secured CE Mark registration for PromarkerD (MS) as an IVD medical device (in vitro diagnostic).
PromarkerD is the world-leading test for predicting the onset of diabetic kidney disease. PromarkerD was registered for use in the Europe Union (EU) as part of the company’s program of future asset registration.
